Phenotypic chemical biology for predicting safety and efficacy
Author:
Open Access
- 1 March 2017
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 23, 53-60
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Applications of Connectivity Map in drug discovery and developmentDrug Discovery Today, 2012
- A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiationNature Chemical Biology, 2012
- RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in RodentsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Open Innovation for Phenotypic Drug Discovery: The PD2 Assay PanelSLAS Discovery, 2011
- How were new medicines discovered?Nature Reviews Drug Discovery, 2011
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug ActivitiesMolecular Cancer Therapeutics, 2010
- Chemical target and pathway toxicity mechanisms defined in primary human cell systemsJournal of Pharmacological and Toxicological Methods, 2010
- Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compoundsNature Reviews Drug Discovery, 2009
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006